Physician profile
Jayce Miskel
NPI 1265819825
$1,278.27
in general payments reported to CMS, 2019-2025
12 companies · $50.14 in 2025
The $50.14 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2021: $115 · 2022: $191 · 2023: $316 · 2024: $96.55 · 2025: $50.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $264.45 | 2021-2025 | |
| Alkermes, INC. | $230.43 | 2019-2023 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $161.13 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $139.64 | 2021-2024 | Caplyta |
| Avanir Pharmaceuticals, INC. | $124.99 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $113.13 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $83.72 | 2021 | |
| Janssen Pharmaceuticals, INC | $67.07 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.59 | 2025 | Cobenfy |
| Lundbeck LLC | $24.10 | 2023 | Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $18.61 | 2024 | Uzedy |
| Takeda Pharmaceuticals U.S.A., INC. | $16.41 | 2024 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayce Miskel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.